Concepedia

Jens Kuhlmann

JK

9

Publications

740

Citations

9

H-Index

1994

Active since

Affiliations

Sterna Biologicals (Germany)(Current)

Bayer (Germany)

University Medical Center Freiburg

Jens Kuhlmann is an author at Sterna Biologicals (Germany) specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

1994–2015

9

Publications

9

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

Franck Morschhauser, John Radford, Achiel Van Hoof et al. · Journal of Clinical Oncology · 2008 · 458 citations

Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath<sup>®</sup>) in patients with chronic lymphocytic leukaemia and its link to treatment response

Diane R. Mould, Andreas Baumann, Jens Kuhlmann et al. · British Journal of Clinical Pharmacology · 2007 · 113 citations · Full text

Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma

Ursula Homburg, Harald Renz, Wolfgang Timmer et al. · Journal of Allergy and Clinical Immunology · 2015 · 46 citations

, , +6

Quantitative PCR Analysis for <i>Bcl-2/IgH</i> in a Phase III Study of Yttrium-90 Ibritumomab Tiuxetan As Consolidation of First Remission in Patients With Follicular Lymphoma

Lindsey K. Goff, Karin E. Summers, Sameena Iqbal et al. · Journal of Clinical Oncology · 2009 · 38 citations

, , +16

Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs

Agnieszka Turowska, Damiano Librizzi, Nadja Baumgartl et al. · Toxicology and Applied Pharmacology · 2013 · 25 citations

, , +8

Rows per page

1–5 of 9